Antimicrobial growth promoter ban and resistance to macrolides and vancomycin in enterococci from pigs

被引:76
作者
Boerlin, P
Wissing, A
Aarestrup, FM
Frey, J
Nicolet, J
机构
[1] Univ Bern, Inst Vet Bacteriol, CH-3012 Bern, Switzerland
[2] Danish Vet Lab, Copenhagen, Denmark
关键词
D O I
10.1128/JCM.39.11.4193-4195.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Ninety-six enterococcus isolates from fecal samples of pigs receiving tylosin as an antimicrobial growth promoter and 59 isolates obtained in the same farms 5 to 6 months after the ban of antimicrobial growth promoters in Switzerland were tested for susceptibility to nine antimicrobial agents. A clear decrease in resistance to macrolides, lincosamides, and tetracycline was visible after the ban. Vancomycin-resistant Enterococcus faecium belonged to the same clonal lineage as vancomycin-resistant isolates previously isolated from Danish pigs.
引用
收藏
页码:4193 / 4195
页数:3
相关论文
共 10 条
[1]   Effect of tylosin used as a growth promoter on the occurrence of macrolide-resistant Enterococci and Staphylococci in pigs [J].
Aarestrup, FM ;
Carstensen, B .
MICROBIAL DRUG RESISTANCE, 1998, 4 (04) :307-312
[2]   Associations between the use of antimicrobial agents for growth promotion and the occurrence of resistance among Enterococcus faecium from broilers and pigs in Denmark, Finland, and Norway [J].
Aarestrup, FM ;
Kruse, H ;
Tast, E ;
Hammerum, AM ;
Jensen, LB .
MICROBIAL DRUG RESISTANCE, 2000, 6 (01) :63-70
[3]   Effect of abolishment of the use of antimicrobial agents for growth promotion on occurrence of antimicrobial resistance in fecal enterococci from food animals in Denmark [J].
Aarestrup, FM ;
Seyfarth, AM ;
Emborg, HD ;
Pedersen, K ;
Hendriksen, RS ;
Bager, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) :2054-2059
[4]   Characterization of glycopeptide-resistant Enterococcus faecium (GRE) from broilers and pigs in Denmark:: Genetic evidence that persistence of GRE in pig herds is associated with coselection by resistance to macrolides [J].
Aarestrup, FM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (07) :2774-2777
[5]   Glycopeptide resistance in Enterococcus faecium from broilers and pigs following discontinued use of avoparcin [J].
Bager, F ;
Aarestrup, FM ;
Madsen, M ;
Wegener, HC .
MICROBIAL DRUG RESISTANCE, 1999, 5 (01) :53-56
[6]   Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms [J].
Bager, F ;
Madsen, M ;
Christensen, J ;
Aarestrup, FM .
PREVENTIVE VETERINARY MEDICINE, 1997, 31 (1-2) :95-112
[7]   DETECTION OF GLYCOPEPTIDE RESISTANCE GENOTYPES AND IDENTIFICATION TO THE SPECIES LEVEL OF CLINICALLY RELEVANT ENTEROCOCCI BY PCR [J].
DUTKAMALEN, S ;
EVERS, S ;
COURVALIN, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) :24-27
[8]   VANA-MEDIATED HIGH-LEVEL GLYCOPEPTIDE RESISTANCE IN ENTEROCOCCUS-FAECIUM FROM ANIMAL HUSBANDRY [J].
KLARE, I ;
HEIER, H ;
CLAUS, H ;
REISSBRODT, R ;
WITTE, W .
FEMS MICROBIOLOGY LETTERS, 1995, 125 (2-3) :165-171
[9]  
*NAT COMM CLIN LAB, 2000, M2A7 NAT COMM CLIN A, V20
[10]  
National Committee for Clinical Laboratory Standards, 2000, M100S10M2 NAT COMM C